Literature DB >> 21489315

Enhanced recovery in colorectal surgery: a multicentre study.

José M Ramírez1, Juan A Blasco, José V Roig, Sergio Maeso-Martínez, José E Casal, Fernando Esteban, Daniel Callejo Lic.   

Abstract

BACKGROUND: Major colorectal surgery usually requires a hospital stay of more than 12 days. Inadequate pain management, intestinal dysfunction and immobilisation are the main factors associated with delay in recovery. The present work assesses the short and medium term results achieved by an enhanced recovery program based on previously published protocols.
METHODS: This prospective study, performed at 12 Spanish hospitals in 2008 and 2009, involved 300 patients. All patients underwent elective colorectal resection for cancer following an enhanced recovery program. The main elements of this program were: preoperative advice, no colon preparation, provision of carbohydrate-rich drinks one day prior and on the morning of surgery, goal directed fluid administration, body temperature control during surgery, avoiding drainages and nasogastric tubes, early mobilisation, and the taking of oral fluids in the early postoperative period. Perioperative morbidity and mortality data were collected and the length of hospital stay and protocol compliance recorded.
RESULTS: The median age of the patients was 68 years. Fifty-two % of the patients were women. The distribution of patients by ASA class was: I 10%, II 50% and III 40%. Sixty-four % of interventions were laparoscopic; 15% required conversion to laparotomy. The majority of patients underwent sigmoidectomy or right hemicolectomy. The overall compliance to protocol was approximately 65%, but varied widely in its different components. The median length of postoperative hospital stay was 6 days. Some 3% of patients were readmitted to hospital after discharge; some 7% required repeat surgery during their initial hospitalisation or after readmission. The most common complications were surgical (24%), followed by septic (11%) or other medical complications (10%). Three patients (1%) died during follow-up. Some 31% of patients suffered symptoms that delayed their discharge, the most common being vomiting or nausea (12%), dyspnoea (7%) and fever (5%).
CONCLUSION: The following of this enhanced recovery program posed no risk to patients in terms of morbidity, mortality and shortened the length of their hospital stay. Overall compliance to protocol was 65%. The following of this program was of benefit to patients and reduces costs by shortening the length of hospital stay. The implantation of such programmes is therefore highly recommended.

Entities:  

Mesh:

Year:  2011        PMID: 21489315      PMCID: PMC3095530          DOI: 10.1186/1471-2482-11-9

Source DB:  PubMed          Journal:  BMC Surg        ISSN: 1471-2482            Impact factor:   2.102


  29 in total

Review 1.  From best evidence to best practice: effective implementation of change in patients' care.

Authors:  Richard Grol; Jeremy Grimshaw
Journal:  Lancet       Date:  2003-10-11       Impact factor: 79.321

2.  Randomised controlled trial investigating the influence of intravenous fluid titration using oesophageal Doppler monitoring during bowel surgery.

Authors:  D H Conway; R Mayall; M S Abdul-Latif; S Gilligan; C Tackaberry
Journal:  Anaesthesia       Date:  2002-09       Impact factor: 6.955

Review 3.  Multimodal approach to control postoperative pathophysiology and rehabilitation.

Authors:  H Kehlet
Journal:  Br J Anaesth       Date:  1997-05       Impact factor: 9.166

4.  Randomised trial of safety and efficacy of immediate postoperative enteral feeding in patients undergoing gastrointestinal resection.

Authors:  C S Carr; K D Ling; P Boulos; M Singer
Journal:  BMJ       Date:  1996-04-06

Review 5.  Current understanding of patients' attitudes toward and preparation for anesthesia: a review.

Authors:  J M Klafta; M F Roizen
Journal:  Anesth Analg       Date:  1996-12       Impact factor: 5.108

6.  Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection.

Authors:  Conor P Delaney; Massarat Zutshi; Anthony J Senagore; Feza H Remzi; Jeffrey Hammel; Victor W Fazio
Journal:  Dis Colon Rectum       Date:  2003-07       Impact factor: 4.585

7.  Requirement for bowel preparation in colorectal surgery.

Authors:  P Burke; K Mealy; P Gillen; W Joyce; O Traynor; J Hyland
Journal:  Br J Surg       Date:  1994-06       Impact factor: 6.939

8.  Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery.

Authors:  Tong J Gan; Andrew Soppitt; Mohamed Maroof; Habib el-Moalem; Kerri M Robertson; Eugene Moretti; Peter Dwane; Peter S A Glass
Journal:  Anesthesiology       Date:  2002-10       Impact factor: 7.892

9.  Randomized clinical trial of multimodal optimization and standard perioperative surgical care.

Authors:  A D G Anderson; C E McNaught; J MacFie; I Tring; P Barker; C J Mitchell
Journal:  Br J Surg       Date:  2003-12       Impact factor: 6.939

10.  A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy.

Authors:  M L Cheatham; W C Chapman; S P Key; J L Sawyers
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

View more
  38 in total

1.  Fast-track for the modern colorectal department.

Authors:  Rishabh Sehgal; Arnold Hill; Joseph Deasy; Deborah A McNamara; Ronan A Cahill
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

2.  Influence of size and complexity of the hospitals in an enhanced recovery programme for colorectal resection.

Authors:  Antonio Arroyo; José Manuel Ramirez; Daniel Callejo; Xavier Viñas; Sergio Maeso; Roger Cabezali; Elena Miranda
Journal:  Int J Colorectal Dis       Date:  2012-05-27       Impact factor: 2.571

Review 3.  Enhancing surgical performance outcomes through process-driven care: a systematic review.

Authors:  Philip H Pucher; Rajesh Aggarwal; Pritam Singh; Ara Darzi
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

4.  The safety of a "fast-track" program after laparoscopic colorectal surgery is comparable in older patients as in younger patients.

Authors:  Se-Jin Baek; Seon-Hahn Kim; Se-Young Kim; Jae-Won Shin; Jung-Myun Kwak; Jin Kim
Journal:  Surg Endosc       Date:  2012-12-12       Impact factor: 4.584

5.  Observational cross-sectional study of compliance with the fast track protocol in elective surgery for colon cancer in Spain.

Authors:  Manuel Alcántara-Moral; X Serra-Aracil; M J Gil-Egea; M Frasson; B Flor-Lorente; E Garcia-Granero
Journal:  Int J Colorectal Dis       Date:  2014-01-17       Impact factor: 2.571

6.  Adherence to ERAS elements in major visceral surgery-an observational pilot study.

Authors:  Steffen Wolk; Marius Distler; Benjamin Müssle; Susanne Söthje; Jürgen Weitz; Thilo Welsch
Journal:  Langenbecks Arch Surg       Date:  2016-03-24       Impact factor: 3.445

7.  "Ultra" E.R.A.S. in laparoscopic colectomy for cancer: discharge after the first flatus? A prospective, randomized trial.

Authors:  Gianluca Garulli; Andrea Lucchi; Pierluigi Berti; Carlo Gabbianelli; Luca Maria Siani
Journal:  Surg Endosc       Date:  2016-08-12       Impact factor: 4.584

8.  The effects of fast-track surgery on inflammation and immunity in patients undergoing colorectal surgery.

Authors:  Jinhua Feng; Ka Li; Li Li; Xiaodong Wang; Mingjun Huang; Jie Yang; Yanjie Hu
Journal:  Int J Colorectal Dis       Date:  2016-08-12       Impact factor: 2.571

Review 9.  The perioperative surgical home (PSH): a comprehensive review of US and non-US studies shows predominantly positive quality and cost outcomes.

Authors:  Bita A Kash; Yichen Zhang; Kayla M Cline; Terri Menser; Thomas R Miller
Journal:  Milbank Q       Date:  2014-12       Impact factor: 4.911

10.  Compliance with enhanced recovery protocols in elderly patients undergoing colorectal resection.

Authors:  S Hallam; F Rickard; N Reeves; D Messenger; J Shabbir
Journal:  Ann R Coll Surg Engl       Date:  2018-06-18       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.